Free Trial
NYSE:IFF

International Flavors & Fragrances Q1 2025 Earnings Report

International Flavors & Fragrances logo
$78.46 +0.91 (+1.17%)
As of 03:59 PM Eastern

International Flavors & Fragrances EPS Results

Actual EPS
N/A
Consensus EPS
$1.09
Beat/Miss
N/A
One Year Ago EPS
N/A

International Flavors & Fragrances Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.83 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

International Flavors & Fragrances Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Wednesday, May 7, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

International Flavors & Fragrances Earnings Headlines

Trump Orders 'National Digital Asset Stockpile'
‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more traction
See More International Flavors & Fragrances Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like International Flavors & Fragrances? Sign up for Earnings360's daily newsletter to receive timely earnings updates on International Flavors & Fragrances and other key companies, straight to your email.

About International Flavors & Fragrances

International Flavors & Fragrances (NYSE:IFF), Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

View International Flavors & Fragrances Profile

More Earnings Resources from MarketBeat